
    
      Twelve healthy subjects will be admitted to a clinical study ward on the Day 0. Physical
      check up and the health status will be confirmed during check in. After fasting for a minimum
      of 10 hours overnight, each subject will be administered a single dose of TRF or Gamma-Delta
      after taking a standardized high-fat meal breakfast on Day 1. Thereafter, standard meals will
      be provided at 4 and 12 hours after dosing. Blood samples (5mL will be taken using an
      in-dwelling canula placed in the antecubital vein immediately before and at 0.5, 1, 2, 3, 4,
      5, 6, 7, 8, 10, 14, and 24 hours after dosing. Subjects will be admitted for 24 hours and
      discharged after the last blood sampling. During the study, blood pressure and the heart rate
      will be monitored regularly for safety profile.

      After a one week wash out period, subject will return to the ward and be given the other
      formulation (TRF or GDT) and the same procedures will be repeated. Any adverse events that
      arise during the treatment will be recorded and followed up till resolution.
    
  